194 related articles for article (PubMed ID: 7758179)
1. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses.
Ajayi AA; Mathur R; Halushka PV
Circulation; 1995 Jun; 91(11):2742-7. PubMed ID: 7758179
[TBL] [Abstract][Full Text] [Related]
2. Castration reduces platelet thromboxane A2 receptor density and aggregability.
Ajayi AA; Halushka PV
QJM; 2005 May; 98(5):349-56. PubMed ID: 15820970
[TBL] [Abstract][Full Text] [Related]
3. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
4. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets.
Matsuda K; Ruff A; Morinelli TA; Mathur RS; Halushka PV
Am J Physiol; 1994 Sep; 267(3 Pt 2):H887-93. PubMed ID: 8092292
[TBL] [Abstract][Full Text] [Related]
5. The Gordon Wilson Lecture. Regulation of thromboxane A2 receptors by testosterone: implications for steroid abuse and cardiovascular disease.
Halushka PV; Masuda A; Matsuda K
Trans Am Clin Climatol Assoc; 1994; 105():95-103. PubMed ID: 7974982
[TBL] [Abstract][Full Text] [Related]
6. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
7. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
8. Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
Dorn GW
J Biol Chem; 1990 Mar; 265(8):4240-6. PubMed ID: 2137820
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
Schrör K; Davis-Bruno K; Halushka PV
Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
[TBL] [Abstract][Full Text] [Related]
10. Sex steroid regulation of thromboxane A2 receptors in cultured rat aortic smooth muscle cells.
Matsuda K; Mathur RS; Ullian ME; Halushka PV
Prostaglandins; 1995 Mar; 49(3):183-96. PubMed ID: 7652187
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of testosterone 5 alpha-reductase: evidence for tissue-specific regulation of thromboxane A2 receptors.
Higashiura K; Blaney B; Morgan E; Mathur RS; Halushka PV
J Pharmacol Exp Ther; 1996 Dec; 279(3):1386-91. PubMed ID: 8968363
[TBL] [Abstract][Full Text] [Related]
13. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
Matsuda K; Mathur RS; Duzic E; Halushka PV
Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549
[TBL] [Abstract][Full Text] [Related]
14. Human platelet aggregation and shape change are coupled to separate thromboxane A2-prostaglandin H2 receptors.
Dorn GW; DeJesus A
Am J Physiol; 1991 Feb; 260(2 Pt 2):H327-34. PubMed ID: 1825455
[TBL] [Abstract][Full Text] [Related]
15. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets.
Folger WH; Halushka PV; Wilcox CS; Guzman NJ
Eur J Pharmacol; 1992 Sep; 227(1):71-8. PubMed ID: 1426024
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane A2 receptors in equine monocytes: identification of a new subclass of TXA2 receptors.
Simmons TR; Cook JA; Moore JN; Halushka PV
J Leukoc Biol; 1993 Feb; 53(2):173-8. PubMed ID: 8383167
[TBL] [Abstract][Full Text] [Related]
18. Characterization of (5Z)-7-[3-endo-[(4-iodophenylsulfonyl) amino] -bicyclo[2.2.1]hep-2-exo-yl]heptenoic acid (IS-145) as an antagonist for the study of thromboxane A2 receptor.
Kan WM; Tai HH
Prostaglandins Leukot Essent Fatty Acids; 1993 Jun; 48(6):439-45. PubMed ID: 8341721
[TBL] [Abstract][Full Text] [Related]
19. Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors.
Dorn GW
Am J Physiol; 1991 Jul; 261(1 Pt 2):R145-53. PubMed ID: 1830459
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
